06/26/2025 7:26 PM | Takeda Pharmaceutical (Subject)
| Form FWP | |
06/26/2025 8:55 PM | Takeda Pharmaceutical (Filer) Takeda U.S. Financing Inc. (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
06/26/2025 5:21 AM | Takeda Pharmaceutical (Filer) Takeda U.S. Financing Inc. (Filer)
| Form 424B5 | |
06/25/2025 6:31 AM | Takeda Pharmaceutical (Filer) Takeda U.S. Financing Inc. (Filer)
| Form F-3ASR | |
06/25/2025 5:23 AM | Takeda Pharmaceutical (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
06/25/2025 5:02 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2025 5:03 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2025 5:04 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2025 5:08 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2025 5:08 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2025 5:01 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for TAK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.
|
06/02/2025 5:06 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 5:27 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 5:12 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 5:14 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 5:20 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2025 5:03 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 5:24 AM | Takeda Pharmaceutical (Filer)
| Form SD Specialized Disclosure Report | |
05/12/2025 5:19 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
05/08/2025 5:14 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2025 5:19 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2025 5:08 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025 5:12 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025 5:07 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025 5:01 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 5:00 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 5:46 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 5:03 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2025 5:40 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/13/2025 5:28 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/13/2025 5:33 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/13/2025 5:06 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2025 5:13 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/12/2025 7:06 AM | Takeda Pharmaceutical (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
01/30/2025 5:24 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 5:25 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 5:28 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 5:29 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 5:23 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 5:01 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024 5:07 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
We’ve Entered the Most Bullish Phase of the Cycle (Ad) It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential.
We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks.
Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap.
And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it. The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin |
12/02/2024 5:00 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 5:28 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 5:19 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 5:21 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 5:01 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024 7:36 PM | Platford Giles Richard (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024 6:46 AM | Takeda Pharmaceutical (Filed by) Xilio Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
07/31/2024 5:02 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2024 6:12 AM | Amakawa Akiko (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:13 AM | Plump Andrew Stewart (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:13 AM | Takeda Pharmaceutical (Subject) Weber Christophe Pierre (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:14 AM | Shannon Elaine Mary (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:15 AM | Ricci Gabriele (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:15 AM | Platford Giles Richard (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:16 AM | Kim Julie So-Young (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:16 AM | Duprey Lauren Rusckowski (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:17 AM | Pignagnoli Agosti Marcello (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:17 AM | Sequeira Ramona (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:18 AM | Bitetti Teresa Marie (Reporting) Takeda Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 6:19 AM | Takeda Pharmaceutical (Subject) Wozniewski Thomas Otto Claus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 5:04 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024 5:05 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2024 10:28 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024 5:20 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 5:33 AM | Takeda Pharmaceutical (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |